| Financial Year |
March 31 2023 |
| Monetary Funds |
1,033,295,120.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
631,000.00 |
| Accounts Receivable |
3,207,435,983.77 |
| Advances to Suppliers |
152,341,703.51 |
| Other Receivables |
-- |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
278,989,793.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
847,465,737.17 |
| Total Current Assets |
7,000,676,926.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
73,506,199.56 |
| Long-term Equity Investment |
725,856,479.62 |
| Investment Properties |
647,460.54 |
| Fixed Assetes |
5,606,892,723.86 |
| Under-construction Projects |
360,229,426.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,851,227,456.29 |
| R&D expenses |
-- |
| Goodwill |
413,104,076.20 |
| Long-Term Deferred and Prepaid Expenses |
116,058,740.54 |
| Deferred Income Tax Assets |
252,405,864.17 |
| Other Non-Current Assets |
8,598,496,103.12 |
| Sub-Total of Non-Current Assets |
27,177,163,134.04 |
| Total Assets |
34,177,840,060.69 |
| Short-Term Loans |
1,608,621,596.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
95,250,821.78 |
| Accounts Payable |
3,101,298,752.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
160,142,422.87 |
| Taxes Payable |
226,365,337.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
689,224,556.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,647,578,713.33 |
| Other Current Liabilities |
592,960,516.15 |
| Sub-Total of Current Liabilities |
9,402,476,774.49 |
| Long-term Loans |
9,816,774,532.20 |
| Bonds Payable |
817,796,974.33 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
34,500,060.43 |
| Deferred Income Tax Liabilities |
514,562,580.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,900,360,876.48 |
| Total Liabilities |
22,302,837,650.97 |
| Paid-In Capital(Or Share Stock) |
815,347,146.00 |
| Capital Surplus |
2,442,269,180.27 |
| Surplus Reserve |
427,524,503.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,422,374,229.73 |
| Minority Stockholder's Interest |
692,176,589.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,182,825,819.93 |
| Owner's Equity（Stockholder's Equity） |
11,875,002,409.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,177,840,060.69 |
